We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B.
- Authors
Gara, N.; Zhao, X.; Collins, M. T.; Chong, W. H.; Kleiner, D. E.; Jake Liang, T.; Ghany, M. G.; Hoofnagle, J. H.
- Abstract
Background Adefovir and tenofovir are nucleotide analogues used as long-term therapy of chronic hepatitis B. Side effects are few, but prolonged and high-dose therapy has been associated with proximal renal tubular dysfunction ( RTD). Aim To assess the incidence of RTD during long-term nucleotide therapy of chronic hepatitis B. Methods A total of 51 patients being treated at the Clinical Center, National Institutes of Health were studied. Diagnosis of RTD required de novo appearance of at least three of five features: hypophosphataemia, hypouricaemia, serum creatinine elevation, proteinuria or glucosuria. Results Among 51 patients treated for 1-10 (mean 7.4) years with adefovir ( n = 42), tenofovir ( n = 4) or adefovir followed by tenofovir ( n = 5), 7 (14%) developed RTD. Time to onset ranged from 22 to 94 (mean 49) months with an estimated 10-year cumulative rate of 15%. All seven had low urinary percent maximal tubular reabsorption of phosphate (<82%). Patients with RTD were older (58 vs. 44 years; P = 0.01) and had lower baseline glomerular filtration rates (82 vs. 97 cc/min; P = 0.08) compared to those without; but did not differ in other features. Six patients with RTD were switched to entecavir, all subsequently had improvements in serum phosphate (2.0-3.0 mg/dL), creatinine (1.6-1.1 mg/dL), uric acid (2.7-3.8 mg/dL) and proteinuria. Conclusions Renal tubular dysfunction develops in 15% of patients treated with adefovir or tenofovir for 2-9 years and is partially reversible with change to other antivirals. Monitoring for serum phosphate, creatinine and urinalysis is prudent during long-term adefovir and tenofovir therapy.
- Subjects
TENOFOVIR; HEPATITIS B; RENAL tubular transport disorders; GLYCOSURIA; CREATININE; URIC acid; URINALYSIS
- Publication
Alimentary Pharmacology & Therapeutics, 2012, Vol 35, Issue 11, p1317
- ISSN
0269-2813
- Publication type
Article
- DOI
10.1111/j.1365-2036.2012.05093.x